IMPORTANCE Clinicians aim to extubate preterm infants as early as possible, to minimize the risks of mechanical ventilation. Extubation is often unsuccessful owing to lung disease or inadequate respiratory drive.
Relevant studies were identified by searching PubMed, The Cochrane Library, and the reference lists of included articles. The PubMed search strategy was (Infant, Premature[Mesh] The primary outcomes were (1) treatment failure (as defined in the studies), and/or (2) reintubation, both within 7 days of extubation. Studies were included if they were randomized clinical trials published in English, enrolled intubated preterm infants (born <37 weeks' gestation), and reported 1 or both primary outcomes. Studies were excluded if they reported intubation solely for surfactant administration followed by rapid extubation. Study protocols, cohort studies, retrospective studies, review articles, abstracts, editorials, and animal studies were excluded.
The titles and abstracts of all retrieved articles were screened independently by 2 investigators (C.T.R. and K.N.F.) to assess the need for further review. Full-text articles were then assessed for inclusion. Disagreements were resolved via consensus of all authors.
Included studies were grouped by intervention tested. Where current Cochrane Reviews included all identified studies of an intervention, the Cochrane Review was cited. When no Cochrane Review existed for an intervention, or the review did not include all identified studies, a new pooled analysis was performed and reported in keeping with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 8 
Statistical Analysis
Additional analyses were performed using the Cochrane Review process (Revman, version 5.3) . 7 Consistent with recommendations made by the Cochrane Neonatal Review Group, a fixed-effects model was used. 9 Where significant heterogeneity between studies was detected (I 2 >50%), an additional random-effects analysis was undertaken (eTable 1 in the Supplement). Outcomes are reported as risk ratio (RR), risk difference (RD), and where a significant difference exists, number needed to treat (NNT). Risk ratio, RD, and NNT are presented as point estimate (95% confidence interval).
Risk of Bias Assessment
Risk of bias was assessed using the Cochrane Collaboration tool (eTable 2 in the Supplement). 7 Strength of evidence across studies was assessed against Grading of Recommendations, Assessment, Development, and Evaluation guidelines (eTables 3-9 in the Supplement).
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Results
The search was conducted on December 23, 2015 December 23, , yielding 1379 articles. An additional 39 articles were identified from Cochrane Reviews. Full-text reviews were conducted on 100 articles, of which 50 were included: 36 were already included in Cochrane Reviews ( Figure 1 ). Three studies had an unacceptably high risk of bias and were excluded.
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Continuous Positive Airway Pressure
Continuous positive airway pressure (CPAP) aims to deliver gas flow at pressures sufficient to maintain airway patency, reducing obstruction, work of breathing, and apnea. Continuous positive airway pressure improves oxygenation and maintains lung volume. 5 Continuous-flow CPAP devices, such as ventilator-generated and bubble CPAP devices, direct a constant gas flow against the resistance of the expiratory limb of the circuit and alter set pressure by varying the area of the expiratory valve opening (ventilator-generated) or underwater depth of the expiratory limb (bubble). 
Nasal Intermittent Positive Pressure Ventilation and Biphasic Positive Airway Pressure
Nasal intermittent positive pressure ventilation (NIPPV) uses a mechanical ventilator to deliver positive pressure inflations on a background of CPAP. The rate, inflation time, and peak inflation pressures used are similar to mechanical ventilation. Nasal intermittent positive pressure ventilation may be synchronized (S-NIPPV) with the infant's spontaneous breathing, or nonsynchronized (NS-NIPPV). Biphasic positive airway pressure (BiPAP) is a variant that cycles between higher and lower set pressures, without coordination with the infant's breathing, and commonly delivered using "variableflow" devices.
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Ten studies were identified investigating post-extubation NIPPV or BiPAP. Eight of these were included in a 2014 Cochrane Review. ,66%) ( Figure 3A 33-39 and eTable 1 in the Supplement). 32 Nasal inter- Nonsynchronized NIPPV or S-NIPPV vs CPAP Seven studies were identified. Nasal intermittent positive pressure ventilation use was associated with a significant decrease in extubation failure (RR, 0.28; 95% CI, 0.18-0.43; RD, −0.28; 95% CI, −0.36 to −0.20; NNT, 4; 95% CI, 2-5; I 2 , 0%).
High-Flow Nasal Cannula Therapy
High-flow nasal cannula (HFNC) uses binasal cannula to deliver heated and humidified blended air and oxygen at gas flows greater than 1 L/min.
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Six studies investigated HFNC therapy post-extubation: 3 studies were included in the 2011 Cochrane Review, and a further 3 studies were identified by our search. 
Interventions for Successful Extubation in Preterm Infants
Original 43 The 223 preterm infants in the post-extubation arm were included in our analysis. There was no difference between the HFNC and CPAP groups in treatment failure: 11 of 107 infants in the HFNC groups (10%) vs 9 of 116 infants in the CPAP group (8%) (P = .51). There was also no difference in the rate of reintubation within 7 days: 11 of 107 infants (10%) vs 12 of 116 infants (10%) (P = .99). About half the infants with treatment failure in the HFNC group were "rescued" from reintubation by CPAP. The rates of reintubation within 7 days were therefore similar: 27 of 152 infants in the HFNC group (18%) vs 38 of 151 infants in the CPAP group (25%) (P = .12). On pooled analysis, there was no difference between HFNC and CPAP in treatment failure within 7 days (RR, 1.11; 95% CI, 0.84-1.47; RD, 0.02; 95% CI, −0.04 to 0.09; I 2 ,55%) ( Figure 4A and eTable 1 in the Supplement) or reintubation within 7 days (RR, 0.94; 95% CI, 0.68-1.31; RD, −0.01; 95% CI, −0.06 to 0.04; I 2 , 64%) ( Figure 4B and eTable 1 in the Supplement). It should be noted that several studies allowed the use of "rescue" CPAP/NIPPV if HFNC had failed prior to reintubation. For the outcome of reintubation, restricting the analysis to trials delivering heated and humidified gas flows of at least 2 L/min reduced the heterogeneity to 0% (RR, 0.78; 95% CI, 0.55-1.12; RD, −0.04; 95% CI, −0.09 to 0.02) (eFigure 2 in the Supplement). 
Humidified vs Nonhumidified HFNC
Methylxanthines
Methylxanthines reduce apneic episodes by increasing respiratory drive. The existing Cochrane Review of this topic included 6 studies, and our search identified an additional 3. 
RR, Fixed (95% CI)
A, Respiratory failure within 7 days of extubation. B, Reintubation within 7 days of extubation. 
Research Original Investigation Interventions for Successful Extubation in Preterm Infants
Chest Physiotherapy
Mechanical ventilation increases lung secretions and can result in lung atelectasis. Active chest physiotherapy, including percussion and vibration, aims to assist in the removal of lung secretions.
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The Cochrane Review included 4 trials comparing the use of active chest physiotherapy both before and after extubation with no active physiotherapy. Meta-analysis found a significant reduction in reintubation within 24 hours with chest physiotherapy (RR, 0.32; 95% CI, 0.13-0.82; RD, −0.07; 95% CI, −0.13 to −0.02; NNT, 15; 95% CI, 7-50; I 2 ; 12%) (eFigure 6 in the Supplement).
Discussion
As clinicians strive to reduce preterm infants' exposure to mechanical ventilation, it is important they are aware of the evidence base for interventions available to aid extubation. To our knowledge, this is the first review compiling the evidence for multiple interventions aimed at improving rates of successful extubation in preterm infants. Continuous positive airway pressure and NIPPV were superior to head-box oxygen. Limited evidence suggested that CPAP delivered at higher pressures (7-9 cm H 2 O) and via binasal prongs was most effective. While CPAP delivered by nasal mask was associated with fewer intubations in the first 72 hours post-extubation in comparison with binasal prongs, this effect was not sustained. No particular method of generating CPAP was found to be superior.
Nasal intermittent positive pressure ventilation was more effective than CPAP to prevent extubation failure, regardless of whether synchronization was used. There was substantial heterogeneity between included trials, partially explained by the inclusion of Kirpalani et al, 31 which differs from other trials in its size, involvement of multiple centers, and different devices. 31 Heterogeneity was partly explained by subgroup analysis, which demonstrated a differential treatment effect; S-NIPPV seemed to have a greater benefit than NS-NIPPV.
High-flow nasal cannula and CPAP appear to have similar efficacy in the prevention of reintubation, although some studies used CPAP as rescue therapy for babies whose HFNC failed. The use of different initial gas flows (range, 1.8-8 L/min) may account for the substantial heterogeneity.
42-44 Excluding
Campbell et al 41 from the reintubation meta-analysis (eFigure2intheSupplement) on the basis that much lower gas flows and unheated gases were used resolves the heterogeneity of the overall pooled analysis. 41 Current evidence does not support any particular HFNC device over another. Methylxanthines improved rates of extubation success; however, doxapram did not. In the Caffeine for Apnea of Prematurity trial, caffeine use in preterm infants was shown to be safe and effective in the short and long term; however, extubation success was not reported.
55,56 On subanalysis, it was
shown that caffeine given pre-extubation reduced time spent in oxygen and rates of death or disability.
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Fixed-effects analysis showed that corticosteroids reduced the rate of reintubation; however, this effect disappeared when a random-effects model was used. The considerable heterogeneity between studies of corticosteroids may be owing to the different doses used (total, 0.25 mg/kg to 1.5 mg/kg). [58] [59] [60] Longer courses of corticosteroids are associated with increased risk of neurodevelopmental problems. 51 Doyle et al 61 demonstrated that infants with a high risk of bronchopulmonary dysplasia had a reduced risk of death or cerebral palsy when exposed to corticosteroids, whereas those at low risk of bronchopulmonary dysplasia had an increased risk.
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Chest physiotherapy significantly improved extubation success; however, this must be interpreted cautiously. The trials have heterogeneous study populations and physiotherapy techniques and were conducted more than 10 years ago. The safety of chest physiotherapy is also questioned.
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This review has several limitations. The large variations between studies in the defined duration of successful extubation and the inconsistent definition of "respiratory failure" make the analysis of pooled data challenging. We noted some instances of substantial heterogeneity (I 2 >50%) between studies, which were explored by conducting random-effects and subgroup analyses based on the characteristics of the intervention. In most cases, the additional analyses did not change our conclusions.
Conclusions
Preterm infants should be extubated to noninvasive respiratory support. Continuous positive airway pressure and NIPPV have the largest evidence base supporting their use. Continuous positive airway pressure should be delivered by binasal prongs or nasal mask and at pressures of at least 5 cm H 2 O. Meta-analysis, including post-extubation treatment by any mode of NIPPV or BiPAP, demonstrates superiority to CPAP in preventing extubation failure. However, translating the evidence for this heterogeneous group of treatments into clinical practice is difficult because there appear to be differences in efficacy between NIPPV and BiPAP modalities. High-flow nasal cannula appears to be a suitable alternative to CPAP, especially if "rescue" CPAP therapy is available. Caffeine should be routinely used in preterm infants undergoing extubation, using the dosages tested in the Caffeine for Apnea of Prematurity trial. 55 Corticosteroids should be used judiciously, weighing up the competing risks of bronchopulmonary dysplasia and neurodevelopmental harm.
Further research is required to determine the best predictors of extubation readiness and the specific noninvasive respiratory support settings and interfaces to be used. A standard definition for defining extubation success and failure should be encouraged to enable synthesis of the evidence. 
